Management and treatment outcomes of rheumatoid arthritis in the era of biologic and targeted synthetic therapies: evaluation of 10-year data from the KURAMA cohort
Introduction (Article introduction authored by Conquest Editorial Team) Over the past two decades, treatment options for rheumatoid arthritis (RA) have evolved significantly. Methotrexate (MTX), biologic disease-modifying antirheumatic drugs (bDMARDs), and…
0 Comments
April 26, 2024